Travere Therapeutics
TVTX
TVTX
173 hedge funds and large institutions have $1.9B invested in Travere Therapeutics in 2023 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 84 increasing their positions, 30 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 154 → 173 (+19)
2.39% more ownership
Funds ownership: 113.66% → 116.05% (+2.4%)
25% less call options, than puts
Call options by funds: $4.63M | Put options by funds: $6.17M
Holders
173
Holding in Top 10
5
Calls
$4.63M
Puts
$6.17M
Top Buyers
| 1 | +$39.5M | |
| 2 | +$35.2M | |
| 3 | +$34M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$30.2M |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$25.8M |
Top Sellers
| 1 | -$83.8M | |
| 2 | -$41.6M | |
| 3 | -$30.6M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$25.8M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$14M |